|  Help  |  About  |  Contact Us

Publication : Behavioral Phenotyping in a Murine Model of <i>GBA1</i>-Associated Parkinson Disease.

First Author  Do J Year  2021
Journal  Int J Mol Sci Volume  22
Issue  13 PubMed ID  34202076
Mgi Jnum  J:313737 Mgi Id  MGI:6751129
Doi  10.3390/ijms22136826 Citation  Do J, et al. (2021) Behavioral Phenotyping in a Murine Model of GBA1-Associated Parkinson Disease. Int J Mol Sci 22(13)
abstractText  Mutations in GBA1, the gene encoding glucocerebrosidase, are common genetic risk factors for Parkinson disease (PD). While the mechanism underlying this relationship is unclear, patients with GBA1-associated PD often have an earlier onset and faster progression than idiopathic PD. Previously, we modeled GBA1-associated PD by crossing gba haploinsufficient mice with mice overexpressing a human mutant alpha-synuclein transgene (SNCA(A53T)), observing an earlier demise, shorter life span and faster symptom progression, although behavioral testing was not performed. To assess whether gba(+)(/-)//SNCA(A53T) mice exhibit a prodromal behavioral phenotype, we studied three cardinal PD features: olfactory discrimination, memory dysfunction, and motor function. The longitudinal performance of gba(+)(/-)//SNCA(A53T) (n = 8), SNCA(A53T) (n = 9), gba(+)(/-) (n = 10) and wildtype (n = 6) mice was evaluated between ages 8 and 23 months using the buried pellet test, novel object recognition test and the beam walk. Fifteen-month-old gba(+)(/-)//SNCA(A53T) mice showed more olfactory and motor deficits than wildtype mice. However, differences between gba(+)(/-)//SNCA(A53T) and SNCA(A53T) mice generally did not reach statistical significance, possibly due to small sample sizes. Furthermore, while gba haploinsufficiency leads to a more rapid demise, this might not result in an earlier prodromal stage, and other factors, including aging, oxidative stress and epigenetics, may contribute to the more fulminant disease course.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression